Inscription Capital LLC Has $1.19 Million Position in Humana Inc. $HUM

Inscription Capital LLC grew its holdings in Humana Inc. (NYSE:HUM) by 224.7% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 4,556 shares of the insurance provider’s stock after buying an additional 3,153 shares during the quarter. Inscription Capital LLC’s holdings in Humana were worth $1,185,000 at the end of the most recent reporting period.

A number of other institutional investors have also made changes to their positions in HUM. Bank of Nova Scotia raised its position in shares of Humana by 219.3% in the 2nd quarter. Bank of Nova Scotia now owns 242,385 shares of the insurance provider’s stock valued at $59,258,000 after acquiring an additional 166,475 shares during the period. Ninety One UK Ltd bought a new stake in Humana in the third quarter valued at approximately $18,613,000. Ethic Inc. raised its holdings in Humana by 174.3% in the third quarter. Ethic Inc. now owns 9,575 shares of the insurance provider’s stock worth $2,491,000 after purchasing an additional 6,084 shares during the period. Fisher Funds Management LTD boosted its position in shares of Humana by 43.1% during the third quarter. Fisher Funds Management LTD now owns 79,282 shares of the insurance provider’s stock worth $20,627,000 after purchasing an additional 23,867 shares in the last quarter. Finally, Mirae Asset Global Investments Co. Ltd. grew its holdings in shares of Humana by 9.2% in the 2nd quarter. Mirae Asset Global Investments Co. Ltd. now owns 16,992 shares of the insurance provider’s stock valued at $4,154,000 after buying an additional 1,432 shares during the period. 92.38% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several analysts recently commented on HUM shares. Guggenheim reaffirmed a “buy” rating on shares of Humana in a research note on Friday, October 3rd. Jefferies Financial Group upgraded Humana from a “hold” rating to a “buy” rating and lifted their price objective for the company from $253.00 to $313.00 in a report on Friday, December 5th. Wells Fargo & Company lowered Humana from an “overweight” rating to a “cautious” rating in a research report on Wednesday, January 7th. Barclays restated an “underperformer” rating on shares of Humana in a report on Monday, January 5th. Finally, Robert W. Baird lowered their price objective on shares of Humana from $280.00 to $264.00 and set a “neutral” rating for the company in a research report on Thursday, December 11th. Eight research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and five have issued a Sell rating to the company. According to data from MarketBeat.com, Humana presently has an average rating of “Hold” and a consensus price target of $293.37.

Humana Trading Down 1.9%

Humana stock opened at $268.12 on Wednesday. The company has a market cap of $32.25 billion, a price-to-earnings ratio of 25.13, a P/E/G ratio of 2.25 and a beta of 0.45. The firm has a 50-day moving average of $256.52 and a 200-day moving average of $264.22. The company has a debt-to-equity ratio of 0.68, a current ratio of 2.02 and a quick ratio of 2.02. Humana Inc. has a one year low of $206.87 and a one year high of $315.35.

Humana (NYSE:HUM) last released its earnings results on Wednesday, November 5th. The insurance provider reported $3.24 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.95 by $0.29. The business had revenue of $32.65 billion for the quarter, compared to analyst estimates of $31.99 billion. Humana had a return on equity of 12.86% and a net margin of 1.02%.Humana’s revenue was up 11.1% on a year-over-year basis. During the same quarter in the prior year, the company posted $4.16 earnings per share. On average, equities analysts expect that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, January 30th. Investors of record on Friday, December 26th will be paid a $0.885 dividend. The ex-dividend date of this dividend is Friday, December 26th. This represents a $3.54 annualized dividend and a dividend yield of 1.3%. Humana’s dividend payout ratio (DPR) is currently 33.18%.

Humana Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.